• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

高中性粒细胞与淋巴细胞比值作为COVID-19患者的预后标志物

High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients.

作者信息

Pimentel Gustavo D, Dela Vega Maria C M, Laviano Alessandro

机构信息

Laboratory of Research in Clinical Nutrition and Sports (Labince), Faculty of Nutrition, Federal University of Goiás, Goiânia, Brazil.

Clinical Hospital, Federal University of Goiás, Goiânia, Brazil.

出版信息

Clin Nutr ESPEN. 2020 Dec;40:101-102. doi: 10.1016/j.clnesp.2020.08.004. Epub 2020 Aug 14.

DOI:10.1016/j.clnesp.2020.08.004
PMID:33183520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7427597/
Abstract

Systemic inflammation has been reported as a new predictor for COVID-19 outcomes. Thus, we highlight in this viewpoint the importance of the neutrophil to lymphocyte ratio in COVID-19 pandemic-infected patients.

摘要

全身炎症已被报道为新冠病毒疾病（COVID-19）预后的一种新预测指标。因此，在本观点文章中，我们强调了中性粒细胞与淋巴细胞比值在COVID-19大流行感染患者中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/7427597/c42258c7ee31/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/7427597/c42258c7ee31/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/7427597/c42258c7ee31/gr1_lrg.jpg

相似文献

1
High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients.高中性粒细胞与淋巴细胞比值作为COVID-19患者的预后标志物
Clin Nutr ESPEN. 2020 Dec;40:101-102. doi: 10.1016/j.clnesp.2020.08.004. Epub 2020 Aug 14.
2
Is neutrophilia associated with mortality in COVID-19 patients? A meta-analysis and meta-regression.中性粒细胞增多与COVID-19患者的死亡率相关吗？一项荟萃分析和元回归分析。
Int J Lab Hematol. 2020 Dec;42(6):e244-e247. doi: 10.1111/ijlh.13298. Epub 2020 Jul 24.
3
[Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].[中性粒细胞与淋巴细胞比值作为新型冠状病毒肺炎的预后标志物]
Medicina (B Aires). 2020;80 Suppl 3:31-36.
4
Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值预测 2019 年冠状病毒病（COVID-19）住院患者的全因死亡率：单中心回顾性队列研究。
Epidemiol Infect. 2020 Sep 9;148:e211. doi: 10.1017/S0950268820002071.
5
Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report.新冠病毒疾病（COVID-19）和非新冠病毒疾病间质性肺炎患者的实验室检查改变：初步报告
J Infect Dev Ctries. 2020 Jul 31;14(7):685-690. doi: 10.3855/jidc.12879.
6
Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.中性粒细胞与淋巴细胞比值可预测轻型新型冠状病毒肺炎患者新冠病毒RNA的清除情况——来自中国武汉东西湖方舱医院的一项回顾性分析
Clin Chem Lab Med. 2020 Jul 1;58(9):e167-e170. doi: 10.1515/cclm-2020-0733. Print 2020 Aug 27.
7
Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.外周血标志物对 2019 年冠状病毒病（COVID-19）的诊断价值：一项多中心、横断面研究。
J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475. Epub 2020 Jul 17.
8
Two consecutive myocardial tissue insults for inpatients with COVID-19.新型冠状病毒肺炎住院患者的连续两次心肌组织损伤。
Crit Care. 2020 May 26;24(1):259. doi: 10.1186/s13054-020-02981-9.
9
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.中性粒细胞与淋巴细胞比值可作为 COVID-19 患者疾病严重程度的潜在生物标志物。
J Glob Antimicrob Resist. 2020 Sep;22:862-863. doi: 10.1016/j.jgar.2020.07.029. Epub 2020 Aug 15.
10
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.嗜酸性粒细胞减少可能是2019冠状病毒病患者的一个相关预后生物标志物。
Allergy Asthma Proc. 2020 Nov 1;41(6):e80-e82. doi: 10.2500/aap.2020.41.200079.

引用本文的文献

1
Neutrophil-to-Lymphocyte Ratio and Cytokine Profiling as Predictors of Disease Severity and Survival in Unvaccinated COVID-19 Patients.中性粒细胞与淋巴细胞比值及细胞因子谱作为未接种疫苗的COVID-19患者疾病严重程度和生存的预测指标
Vaccines (Basel). 2024 Jul 31;12(8):861. doi: 10.3390/vaccines12080861.
2
Inflammatory Biomarkers for Assessing In-Hospital Mortality Risk in Severe COVID-19-A Retrospective Study.用于评估重症新型冠状病毒肺炎住院死亡风险的炎症生物标志物——一项回顾性研究
J Pers Med. 2024 May 10;14(5):503. doi: 10.3390/jpm14050503.
3
Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) - Risk of Death Inflammatory Biomarkers in Patients with COVID-19.

本文引用的文献

1
The CALL Score for Predicting Outcomes in Patients With COVID-19.预测COVID-19患者预后的CALL评分
Clin Infect Dis. 2021 Jan 23;72(1):182-183. doi: 10.1093/cid/ciaa686.
2
High neutrophil to lymphocytes ratio is associated with sarcopenia risk in hospitalized cancer patients.高中性粒细胞与淋巴细胞比值与住院癌症患者发生肌肉减少症的风险相关。
Clin Nutr. 2021 Jan;40(1):202-206. doi: 10.1016/j.clnu.2020.05.005. Epub 2020 May 11.
3
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line.
中性粒细胞/淋巴细胞比值（NLR）和淋巴细胞/单核细胞比值（LMR）——COVID-19患者死亡风险的炎症生物标志物
J Inflamm Res. 2023 May 23;16:2209-2222. doi: 10.2147/JIR.S409871. eCollection 2023.
4
The Value of Early and Follow-Up Elevated Scores Based on Peripheral Complete Blood Cell Count for Predicting Adverse Outcomes in COVID-19 Patients.基于外周全血细胞计数的早期及随访升高分数对预测COVID-19患者不良结局的价值
J Pers Med. 2022 Dec 9;12(12):2037. doi: 10.3390/jpm12122037.
5
COVID-19: Lessons on malnutrition, nutritional care and public health from the ESPEN-WHO Europe call for papers.COVID-19：ESPEN-WHO 欧洲论文征集活动对营养不良、营养护理和公共卫生的启示。
Clin Nutr. 2022 Dec;41(12):2858-2868. doi: 10.1016/j.clnu.2022.07.033. Epub 2022 Aug 11.
6
Novel Scoring Systems to Predict the Need for Oxygenation and ICU Care, and Mortality in Hospitalized COVID-19 Patients: A Risk Stratification Tool.预测住院COVID-19患者氧疗需求、重症监护需求及死亡率的新型评分系统：一种风险分层工具
Cureus. 2022 Jul 29;14(7):e27459. doi: 10.7759/cureus.27459. eCollection 2022 Jul.
7
The Role of Neutrophil-to-Lymphocyte Ratio in Risk Stratification and Prognostication of COVID-19: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在COVID-19风险分层和预后评估中的作用：一项系统评价和荟萃分析
Vaccines (Basel). 2022 Aug 1;10(8):1233. doi: 10.3390/vaccines10081233.
8
Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity.中性粒细胞与淋巴细胞、单核细胞与淋巴细胞、血小板与淋巴细胞及平均血小板体积与血小板比值在区分新冠病毒疾病严重程度方面的性别差异表现
Front Cardiovasc Med. 2022 Apr 8;9:822556. doi: 10.3389/fcvm.2022.822556. eCollection 2022.
9
Graphene-Based Biosensors for Molecular Chronic Inflammatory Disease Biomarker Detection.基于石墨烯的生物传感器用于分子慢性炎症性疾病生物标志物检测。
Biosensors (Basel). 2022 Apr 14;12(4):244. doi: 10.3390/bios12040244.
10
A robust and parsimonious machine learning method to predict ICU admission of COVID-19 patients.一种用于预测新冠肺炎患者入住重症监护病房的强大且简约的机器学习方法。
Med Biol Eng Comput. 2022 Mar 30:1-13. doi: 10.1007/s11517-022-02543-x.
新冠病毒肺炎中中性粒细胞与淋巴细胞比值及临床结局：来自意大利前线的报告
Int J Antimicrob Agents. 2020 Aug;56(2):106017. doi: 10.1016/j.ijantimicag.2020.106017. Epub 2020 May 11.
4
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分，以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
5
[An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19].中性粒细胞/淋巴细胞比值升高是重症新型冠状病毒肺炎的早期预警信号。
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Mar 30;40(3):333-336. doi: 10.12122/j.issn.1673-4254.2020.03.06.
6
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
7
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.血浆 IP-10 和 MCP-3 水平与疾病严重程度高度相关，并可预测 COVID-19 的进展。
J Allergy Clin Immunol. 2020 Jul;146(1):119-127.e4. doi: 10.1016/j.jaci.2020.04.027. Epub 2020 Apr 29.
8
Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.中国温州地区 COVID-19 患者外周血象系统的异常。
Clin Chim Acta. 2020 Aug;507:174-180. doi: 10.1016/j.cca.2020.04.024. Epub 2020 Apr 24.
9
Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19.COVID-19 聚集性发病患者的流行病学和初步临床特征。
J Clin Virol. 2020 Jun;127:104360. doi: 10.1016/j.jcv.2020.104360. Epub 2020 Apr 12.
10
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.